The Generation of Nitric Oxide from Aldehyde Dehydrogenase-2: The Role of Dietary Nitrates and Their Implication in Cardiovascular Disease Management
- PMID: 36555095
- PMCID: PMC9779284
- DOI: 10.3390/ijms232415454
The Generation of Nitric Oxide from Aldehyde Dehydrogenase-2: The Role of Dietary Nitrates and Their Implication in Cardiovascular Disease Management
Abstract
Reduced bioavailability of the nitric oxide (NO) signaling molecule has been associated with the onset of cardiovascular disease. One of the better-known and effective therapies for cardiovascular disorders is the use of organic nitrates, such as glyceryl trinitrate (GTN), which increases the concentration of NO. Unfortunately, chronic use of this therapy can induce a phenomenon known as "nitrate tolerance", which is defined as the loss of hemodynamic effects and a reduction in therapeutic effects. As such, a higher dosage of GTN is required in order to achieve the same vasodilatory and antiplatelet effects. Mitochondrial aldehyde dehydrogenase 2 (ALDH2) is a cardioprotective enzyme that catalyzes the bio-activation of GTN to NO. Nitrate tolerance is accompanied by an increase in oxidative stress, endothelial dysfunction, and sympathetic activation, as well as a loss of the catalytic activity of ALDH2 itself. On the basis of current knowledge, nitrate intake in the diet would guarantee a concentration of NO such as to avoid (or at least reduce) treatment with GTN and the consequent onset of nitrate tolerance in the course of cardiovascular diseases, so as not to make necessary the increase in GTN concentrations and the possible inhibition/alteration of ALDH2, which aggravates the problem of a positive feedback mechanism. Therefore, the purpose of this review is to summarize data relating to the introduction into the diet of some natural products that could assist pharmacological therapy in order to provide the NO necessary to reduce the intake of GTN and the phenomenon of nitrate tolerance and to ensure the correct catalytic activity of ALDH2.
Keywords: aldehyde dehydrogenase 2 (ALDH2); endothelium; nitrate tolerance; nitrate–nitrite intake; nitric oxide (NO); oxidative stress.
Conflict of interest statement
The authors declare no conflict of interest.
Figures





Similar articles
-
The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: role in nitrate tolerance.Pharmacol Res. 2014 Nov;89:29-35. doi: 10.1016/j.phrs.2014.07.007. Epub 2014 Aug 28. Pharmacol Res. 2014. PMID: 25174989
-
Aldehyde dehydrogenase 2 protects human umbilical vein endothelial cells against oxidative damage and increases endothelial nitric oxide production to reverse nitroglycerin tolerance.Genet Mol Res. 2016 Jun 10;15(2). doi: 10.4238/gmr.15027822. Genet Mol Res. 2016. PMID: 27323160
-
Changes in aldehyde dehydrogenase 2 expression in rat blood vessels during glyceryl trinitrate tolerance development and reversal.Br J Pharmacol. 2011 Sep;164(2b):632-43. doi: 10.1111/j.1476-5381.2011.01448.x. Br J Pharmacol. 2011. PMID: 21506955 Free PMC article.
-
[Recent findings on nitrates: their action, bioactivation and development of tolerance].Dtsch Med Wochenschr. 2008 Oct;133(44):2277-82. doi: 10.1055/s-0028-1091272. Epub 2008 Oct 22. Dtsch Med Wochenschr. 2008. PMID: 18946854 Review. German.
-
Glyceryl Trinitrate: History, Mystery, and Alcohol Intolerance.Molecules. 2021 Oct 30;26(21):6581. doi: 10.3390/molecules26216581. Molecules. 2021. PMID: 34770988 Free PMC article. Review.
Cited by
-
Aldehyde Dehydrogenase 2 rs671 Polymorphism is Associated with Susceptibility of Coronary Atherosclerosis in Patients with Hypertension.Int J Gen Med. 2025 Feb 10;18:681-690. doi: 10.2147/IJGM.S501396. eCollection 2025. Int J Gen Med. 2025. PMID: 39959460 Free PMC article.
-
ALDH2 Enzyme Deficiency in Diabetic Cardiomyopathy.Int J Mol Sci. 2025 Jun 9;26(12):5516. doi: 10.3390/ijms26125516. Int J Mol Sci. 2025. PMID: 40564981 Free PMC article. Review.
-
Mechanisms and preventive measures of ALDH2 in ischemia‑reperfusion injury: Ferroptosis as a novel target (Review).Mol Med Rep. 2025 Apr;31(4):105. doi: 10.3892/mmr.2025.13470. Epub 2025 Feb 28. Mol Med Rep. 2025. PMID: 40017132 Free PMC article. Review.
-
The Antioxidant Power of Bergamot Polyphenolic Fraction Gold Potentiates the Effects of L-Citrulline in Athlete Performance and Vasodilation in a Pilot Study.Nutrients. 2025 Mar 21;17(7):1106. doi: 10.3390/nu17071106. Nutrients. 2025. PMID: 40218864 Free PMC article. Clinical Trial.
-
Nutraceuticals and Human Health and Disease.Nutrients. 2025 Apr 24;17(9):1432. doi: 10.3390/nu17091432. Nutrients. 2025. PMID: 40362740 Free PMC article.
References
-
- Mollace V., Muscoli C., Dagostino C., Giancotti L.A., Gliozzi M., Sacco I., Visalli V., Gratteri S., Palma E., Malara N., et al. The effect of peroxynitrite decomposition catalyst MnTBAP on aldehyde dehydrogenase-2 nitration by organic nitrates: Role in nitrate tolerance. Pharmacol. Res. 2014;89:29–35. doi: 10.1016/j.phrs.2014.07.007. - DOI - PubMed
-
- Salvemini D., Mollace V., Pistelli A., Anggard E., Vane J. Metabolism of glyceryl trinitrate to nitric oxide by endothelial cells and smooth muscle cells and its induction by Escherichia coli lipopolysaccharide. Proc. Natl. Acad. Sci. USA. 1992;89:982–986. doi: 10.1073/pnas.89.3.982. - DOI - PMC - PubMed
-
- Arif S., Borgognone A., Lin E.L., O’Sullivan A.G., Sharma V., Drury N.E., Menon A., Nightingale P., Mascaro J., Bonser R.S., et al. Role of aldehyde dehydrogenase in hypoxic vasodilator effects of nitrite in rats and humans. Br. J. Pharmacol. 2015;172:3341–3352. doi: 10.1111/bph.13122. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous